July 20, 2017
Researchers have found that some people with chronic hepatitis C virus (HCV) in high-income countries also have mental health and substance use issues. At least two studies have found that people with HCV are more likely to have illnesses such as schizophrenia and bipolar disorder than the average person without HCV. It is possible that some people with HCV who also have undiagnosed, untreated or poorly managed mental health conditions may not be able to fully engage with their overall care and their treatment of HCV unless they get adequate support.
To investigate the intersection of mental health, substance use and HCV treatment, researchers at several community health centres in San Diego undertook a study.
The researchers reviewed the clinics' healthcare records and found the following:
Among all 3,233 people with HCV, researchers stated that nearly 78% had a "mental health and/or substance abuse diagnosis." The specific diagnoses were distributed as follows:
Among the 434 people who had taken or were currently taking HCV treatment, researchers found that 78% had "either a substance abuse, a mental health diagnosis or both."
Among all 3,233 people diagnosed with HCV infection, common additional diagnoses were as follows:
Among the people who had taken or who were currently taking HCV treatment, the most common additional diagnoses were as follows:
According to the San Diego researchers, here were some key points from their study:
"Mental health and substance abuse issues are common in our urban, underserved, primary care-based HCV treatment program."
The researchers said that having both "mental health and substance diagnoses" was not a barrier to successful HCV treatment.
The study team encouraged other care providers to identify these co-morbidities before HCV treatment is initiated or during HCV treatment. Once identified, the diagnosis of these co-morbidities could serve as an opportunity to offer services such as "case management, behavioural therapy, rehabilitation services and group therapy." Such interventions could help improve success rates with HCV treatment and the overall health and quality of life of people struggling with mental health and addiction issues.
Nateras A, Wallace D, Moreau M, et al. High prevalence of concomitant substance abuse and mental health disorders in an urban underserved FQHC-based HCV treatment program. In: Program and abstracts of the International Liver Congress, 19-23 April 2017, Amsterdam, the Netherlands. Poster 200.
|Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients|
|Improvements in Mood and Energy After Successful HCV Treatments|
|What Will It Take to Eliminate HCV in the U.S.? The WHO Global Hepatitis Report Puts It Into the Global Context|
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade|
|CROI 2018: Highlights and What's Next for Advocates|
|Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence|
|Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives|
|Statin Use Might Reduce Risk of Cancer in HIV-Positive People|
|Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say|